We develop and market generic medicines that combine high quality with cost efficiency.
Today, on 20 August 2026, the annual general meeting was held in EQL Pharma AB. A summary of the adopted resolutions follows below.
Through scientific precision, smarter processes, and close collaboration with development partners, we make proven treatments more accessible to patients across multiple countries—every day.
Products that are sold at pharmacies through so-called exchange systems
Products handled by healthcare professionals
Niche generics that are actively marketed by EQL or collaboration partners
Non-substitutable generics
We are always looking for talented new colleagues to join our team. Our headquarters are located in Lund, Sweden, and we have team members across India and around the world. Learn more about our opportunities and we look forward to receiving your application.
